3-Oxo-2-phenyl-2,3-dihydro-1H-isoindole-4-carboxylic acid, 50mg

(tert-Butoxycarbonyl)-L-prolylglycine, 95%, 500mg

(2E)-3-(2,3-dimethoxyphenyl)-1-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

6-CHLORO-5-FLUORO-2,3-DIHYDRO-1H-INDEN-1-AMINE, 95.0%, 250mg

Single-channel microliter pipette Pipetman® G, 1 to 10 µl, P10G, 1 piece

1-tert-Butoxycarbonyl-4-hydroxypiperidine, 98.0%, 25g

(3-(N-Ethylsulfamoyl)phenyl)boronic acid, 98%, 5g

2-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine, 97%, 250mg

4-Benzyl N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-aspartate>98.0%(HPLC)(T)25g

N-(1-benzylpyrrolidin-3-yl)-2,2,2-trifluoroacetamide, 98%, 25g

Ethyl 2-(5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl)acetate hydrochloride, 95+%, 250mg

Boc-NH-PEG12-NH2, 1g

10-(1H-imidazol-1-yl)decan-1-ol, 95+%, 1g